metformin and peptide yy

metformin has been researched along with peptide yy in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ashcroft, A; Bloom, SR; Dovey, TM; Eccleston, D; English, PJ; Ghatei, MA; Halford, JC; Harrison, J; Patterson, M; Wilding, JP1
Al-Zaman, Y; Aylwin, S1
Batterham, RL; Conway, GS; Tsilchorozidou, T1
Aaboe, K; Deacon, CF; Holst, JJ; Knop, FK; Krarup, T; Madsbad, S; Vilsbøll, T1
Apseloff, G; Atiee, G; Bush, MA; Collins, DA; Corsino, L; Feldman, PL; Gillmor, D; McMullen, SL; Morrow, L; Nunez, DJ1
Baker, D; Brown, JR; Miller, S; Napolitano, A; Nicholls, AW; Nunez, DJ; Rajpal, D; Spivak, A; Thomas, E; Van Horn, S1
Baron, A; Burns, C; Buse, JB; DeFronzo, RA; Fineman, M; Kim, T; Skare, S1
de Fontgalland, D; Hollington, P; Keating, DJ; Martin, AM; Rabbitt, P; Sun, EW; Wattchow, DA; Young, RL1

Reviews

1 review(s) available for metformin and peptide yy

ArticleYear
Emerging concepts in the medical and surgical treatment of obesity.
    Frontiers of hormone research, 2008, Volume: 36

    Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide

2008

Trials

5 trial(s) available for metformin and peptide yy

ArticleYear
Metformin increases fasting plasma peptide tyrosine tyrosine (PYY) in women with polycystic ovarian syndrome (PCOS).
    Clinical endocrinology, 2008, Volume: 69, Issue:6

    Topics: Adult; Fasting; Female; Humans; Metformin; Peptide YY; Polycystic Ovary Syndrome; Waist Circumference; Weight Loss

2008
Twelve weeks treatment with the DPP-4 inhibitor, sitagliptin, prevents degradation of peptide YY and improves glucose and non-glucose induced insulin secretion in patients with type 2 diabetes mellitus.
    Diabetes, obesity & metabolism, 2010, Volume: 12, Issue:4

    Topics: Adult; Aged; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Administration Schedule; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Metformin; Middle Aged; Peptide YY; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles

2010
Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Male; Mesylates; Metformin; Middle Aged; Oxadiazoles; Peptide YY; Prognosis; Pyrazines; Receptors, G-Protein-Coupled; Sitagliptin Phosphate; Triazoles

2014
Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.
    PloS one, 2014, Volume: 9, Issue:7

    Topics: Adolescent; Adult; Aged; Bile Acids and Salts; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Intestinal Mucosa; Intestines; Male; Metformin; Microbiota; Middle Aged; Peptide YY

2014
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials.
    Diabetologia, 2016, Volume: 59, Issue:8

    Topics: Adult; Blood Glucose; Cross-Over Studies; Fasting; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Peptide YY; Postprandial Period

2016

Other Studies

2 other study(ies) available for metformin and peptide yy

ArticleYear
Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes.
    Diabetes/metabolism research and reviews, 2007, Volume: 23, Issue:4

    Topics: Adult; Appetite; Diabetes Mellitus, Type 2; Energy Metabolism; Female; Ghrelin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Osmolar Concentration; Peptide Hormones; Peptide YY; Postprandial Period; Satiety Response; Thermogenesis

2007
Metformin Triggers PYY Secretion in Human Gut Mucosa.
    The Journal of clinical endocrinology and metabolism, 2019, 07-01, Volume: 104, Issue:7

    Topics: Adult; Aged; AMP-Activated Protein Kinases; Colon; Diabetes Mellitus, Type 2; Enteroendocrine Cells; Equilibrative Nucleoside Transport Proteins; Female; Humans; Hypoglycemic Agents; Ileum; Intestinal Mucosa; Male; Metformin; Middle Aged; Peptide YY; Serotonin Plasma Membrane Transport Proteins; Weight Loss

2019